Polen Capital Management’s Mesoblast MESO Stock Holding History

Polen Capital Management’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,005	Closed	-$415K	–	258
2025 Q4	$415K	Buy	+23,005	New	+$396K	﹤0.01%	188

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Polen Capital Management's MESO Position: Q1 2026 in Review

Polen Capital Management sold out of Mesoblast (MESO) in Q1 2026, closing a stake of 23,005 shares — an estimated $415K sold.

Polen Capital Management first reported a position in MESO in Q4 2025 and held it in 1 quarter. The position peaked at $415K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

Polen Capital Management reported no remaining Mesoblast position as of Q1 2026 after selling out during the quarter.
Polen Capital Management sold 23,005 Mesoblast shares in Q1 2026, an estimated $415K.
Polen Capital Management first reported a position in Mesoblast in Q4 2025 and held it in 1 quarter.
Polen Capital Management's Mesoblast position peaked at $415K in Q4 2025.
69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Polen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.